Smallpox vaccine: Bavarian Nordic announces topline results from study on freeze-dried formulation
by Press Release from Outbreak News Today on (#57B2V)
Bavarian Nordic A/S announced topline results from the pivotal Phase 3 study of the freeze-dried formulation of its MVA-BN(R) smallpox vaccine. The Phase 3 lot-consistency study was agreed with the U.S. Food and Drug Administration (FDA) as the only Phase 3 study required to support licensure of the freeze-dried formulation. The liquid-frozen formulation of the vaccine [...]
The post Smallpox vaccine: Bavarian Nordic announces topline results from study on freeze-dried formulation appeared first on Outbreak News Today.